Get the Stockscreener App
1.10
0.46%
0.01
Cocrystal Pharma Inc stock is traded at $1.10, with a volume of 36,491.
It is up +0.46% in the last 24 hours and up +7.35% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.09
Open:
$1.1
24h Volume:
36,491
Relative Volume:
0.31
Market Cap:
$15.16M
Revenue:
-
Net Income/Loss:
$-17.93M
P/E Ratio:
-0.6215
EPS:
-1.77
Net Cash Flow:
$-14.28M
1W Performance:
+15.42%
1M Performance:
+7.35%
6M Performance:
-27.96%
1Y Performance:
-54.37%
1-Day Range:
$1.08
$1.12
1-Week Range:
$0.91
$1.12
52-Week Range:
$0.90
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.10 | 15.02M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.16 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
774.22 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.06 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
802.27 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.79 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
Phillip Md Et Al Frost Purchases 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock - Defense World
Buyback Watch: How analysts rate Cocrystal Pharma Inc stock todayBull Run & Weekly Watchlist for Hot Stocks - moha.gov.vn
Financial Survey: CytomX Therapeutics (NASDAQ:CTMX) versus Cocrystal Pharma (NASDAQ:COCP) - Defense World
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k By Investing.com - Investing.com Nigeria
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k - Investing.com
Aug Decliners: Will Cocrystal Pharma Inc. stock split attract more investors - moha.gov.vn
Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - Улправда
Why Cocrystal Pharma Inc. stock is a must watch in 2025Market Performance Summary & Safe Entry Momentum Stock Tips - Улправда
Rally Mode: Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reports2025 Trade Ideas & Safe Capital Growth Stock Tips - Улправда
Why Cocrystal Pharma Inc. (8CC) stock could be top winnerJuly 2025 Sentiment & High Conviction Investment Ideas - moha.gov.vn
Is Cocrystal Pharma Inc. stock a safe haven assetJuly 2025 Price Swings & AI Powered Market Entry Strategies - DonanımHaber
Will Cocrystal Pharma Inc. stock gain from government policiesMarket Volume Summary & Long-Term Capital Growth Ideas - bolumsonucanavari.com
Will Cocrystal Pharma Inc. stock split attract more investorsEarnings Overview Summary & Weekly High Potential Alerts - DonanımHaber
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial By Investing.com - Investing.com Australia
Should I hold or sell Cocrystal Pharma Inc. stock in 2025Market Growth Report & Long-Term Safe Return Strategies - Bölüm Sonu Canavarı
Can Cocrystal Pharma Inc. stock deliver strong Q4 earnings2025 EndofYear Setup & High Conviction Buy Zone Picks - DonanımHaber
Sentiment Recap: Why Cocrystal Pharma Inc. stock is a must watch in 2025Dip Buying & Short-Term High Return Ideas - Улправда
[8-K] Cocrystal Pharma, Inc. Reports Material Event | COCP SEC FilingForm 8-K - Stock Titan
Cocrystal Pharma, Inc. Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - marketscreener.com
Cocrystal Pharma (COCP) Set to Begin Norovirus Study with IRB Ap - GuruFocus
Cocrystal Pharma gains IRB approval for norovirus trial - TipRanks
Cocrystal Pharma Initiates Phase 1b Study for Norovirus Treatment - TradingView — Track All Markets
Cocrystal Pharma receives IRB approval from Emory University School of Medicine - marketscreener.com
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial - Investing.com
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - GlobeNewswire
Human trial of first oral drug to fight norovirus cleared at Emory - Stock Titan
Cocrystal Pharma (NASDAQ:COCP) Shares Down 3.5% – Here’s What Happened - Defense World
Cocrystal Pharma Earnings Notes - Trefis
EPS Watch: Can Cocrystal Pharma Inc. stock deliver strong Q4 earningsQuarterly Investment Review & Reliable Intraday Trade Alerts - moha.gov.vn
Portfolio Update: Is Cocrystal Pharma Inc stock trading near support levelsWeekly Investment Report & Low Risk Investment Opportunities - moha.gov.vn
Revenue per share of Cocrystal Pharma Inc – FWB:8CC - TradingView
Why institutional investors increase stakes in Cocrystal Pharma Inc. (8CC) stockJuly 2025 Review & AI Optimized Trade Strategies - Newser
Published on: 2025-12-02 05:48:00 - Newser
How Cocrystal Pharma Inc. (8CC) stock valuation compares with sectorBond Market & Reliable Price Breakout Signals - Newser
How Cocrystal Pharma Inc. (8CC) stock behaves under inflation pressureWeekly Market Summary & Weekly High Return Opportunities - Newser
Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Expert-Curated Trade Recommendations - Newser
Cocrystal Pharma to Present at Emerging Growth Conference - TipRanks
Cocrystal Pharma to Present at Noble Capital Markets Conference - TradingView
COCP Insider Trading - Quiver Quantitative
Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference - Quiver Quantitative
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference - marketscreener.com
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 - Investing.com
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB By Investing.com - Investing.com South Africa
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 - Investing.com India
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 By Investing.com - Investing.com Australia
COCP insider Phillip Frost updates holdings after 20,000-share trade - Stock Titan
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cocrystal Pharma Inc Stock (COCP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
2.45%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):